Author

M. Sverdlov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Approach:biophysical modeling· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Das Gupta· 1 shared A. J. Smith· 1 shared A. M. Gajda· 1 shared A. T. Nelczyk· 1 shared C. P. Schane· 1 shared E. C. Fink· 1 shared E. E. Er· 1 shared E. Jacquin· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Das Gupta

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJan 3, 2024

Multiplex Imaging Reveals Novel Subcellular, Microenvironmental, and Racial Patterns of MRTFA/B Activation in Invasive Breast Cancers and Metastases

S. M. Wilk, K. Lee, A. M. Gajda…·E. E. Er

The paper uses multiplex imaging and bioinformatics to show distinct MRTFA/B activation patterns in breast cancer subtypes and racial disparities in MRTFA expression.

DOI 10.1101/2024.01.03.573909

humanimaging

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 14, 2023

Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression

H. E. V. Gamage, S. H. Shahoei, S. T. Albright…·E. R. Nelson

This paper shows that NR0B2 in myeloid cells reduces Treg expansion and tumor growth by modulating the NLRP3 inflammasome, with small molecule agonists improving ICB efficacy in breast cancer.

DOI 10.1101/2023.08.14.553229

mouseexperimental assay

𝕏 PostBluesky